Compounded Semaglutide
The one you have heard your friends talk about. Adults who want steady, provider-guided weight loss and prefer the most established GLP-1 option. Your provider reviews your health history to decide whether it is right for you.
How it works
Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your gut already makes, one that tells your brain you are full and slows how fast your stomach empties. The result for most people is less hunger, fewer cravings, and smaller portions that still feel satisfying. It is taken as a once-weekly injection under the skin.
Your provider starts you low and adjusts over time.
Who it is for
Adults who want steady, provider-guided weight loss and prefer the most established GLP-1 option. Your provider reviews your health history to decide whether it is right for you.
This is not about willpower, friend. It is about giving your body the same help science has been handing out in doctors' offices for years, with a team that actually listens.
What is included
- Care from a licensed provider, start to finish
- Your medication shipped to your door, refrigerated and ready
- Syringes and alcohol pads in every kit
- Check-ins and dose guidance from the Meri care team
- Member-platform access and educational content
| Monthly · 0.25 to 1 mg weekly | $190/mo |
| 3-month supply · Save vs monthly | $399 ($133/mo) |
| 6-month supply | $714 ($119/mo) |
| 12-month supply · Best value | $1188 ($99/mo) |
First month at the intro price, then the selected plan price shown. Only if a provider prescribes.
Common side effects
The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, and lower appetite. They are usually mild and settle as your body adjusts, and starting at a low dose helps.
Serious risks to know
Serious but less common risks include inflammation of the pancreas, gallbladder problems, kidney strain from dehydration, low blood sugar (especially if you also take insulin or a sulfonylurea), and allergic reactions. In animal studies GLP-1 medicines caused thyroid tumors; the risk in people is not known, which is why the thyroid-history questions matter. Tell your provider about any severe belly pain, trouble breathing, or swelling.
Before you start
A provider will not prescribe semaglutide if any of the following apply to you. Please be honest in your visit, these questions keep you safe.
- A personal or family history of medullary thyroid carcinoma (a type of thyroid cancer)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- Pregnant, breastfeeding, or planning to become pregnant
- A history of pancreatitis (inflammation of the pancreas)
- Type 1 diabetes, or a history of diabetic ketoacidosis
- A previous serious allergic reaction to semaglutide, tirzepatide, or any GLP-1 medication
- Severe stomach or intestinal disease, such as Crohn's disease, ulcerative colitis, or gastroparesis (slow stomach emptying)
- Active gallbladder disease
- Bariatric or other stomach or intestinal surgery in the last 6 months
- Liver disease or cirrhosis
- Kidney disease or a history of kidney failure
Prescription products are issued only when clinically appropriate after an evaluation by a licensed provider. Payment does not guarantee that a prescription will be issued or that medication will be dispensed.
Compounded medications are not FDA-approved. The U.S. Food and Drug Administration (FDA) does not review compounded medications for safety, effectiveness, or quality before they are marketed. They are prepared by licensed compounding pharmacies in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act, based on a valid patient-specific prescription from a licensed provider.
Meri Health does not manufacture compounded medications. Actual product appearance and labeling may differ from images shown on this website.
FDA-approved brand-name medications, including Wegovy and Ozempic, are manufactured by Novo Nordisk. Mounjaro and Zepbound are manufactured by Eli Lilly and Company. Meri Health is not affiliated with, endorsed by, or sponsored by these companies or their products.